Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Underrepresentation of Older Adults in Clinical Trials of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hematologic Malignancies: An FDA Analysis

Pamela Seam, Upendra Mahat, Najat Bouchkouj, Poornima Sharma, Helka Peredo-Pinto, Mona Elmacken, Megha Kaushal, Yuxia Jia, Shu Wang, Zhiheng Xu, Yvette Kasamon, Bindu Kanaparu, Nicholas Richardson, Nicole Gormley

Blood (2023) 142 (Supplement 1): 6919.

https://doi.org/10.1182/blood-2023-186544

Published: 2023

Journal Articles

Underrepresentation of Racial and Ethnic Minorities in Registrational Chimeric Antigen Receptor (CAR) T-Cell Therapy Trials in Hematologic Malignancies: An FDA Analysis

Upendra Mahat, Pamela Seam, Najat Bouchkouj, Poornima Sharma, Helka Peredo-Pinto, Mona Elmacken, Megha Kaushal, Shu Wang, Zhiheng Xu, Yuxia Jia, Nicholas Richardson, Bindu Kanapuru, Yvette Kasamon, Nicole Gormley

Blood (2023) 142 (Supplement 1): 4874.

https://doi.org/10.1182/blood-2023-182279

Published: 2023

Journal Articles

Eligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trials

Bindu Kanapuru, Laura L. Fernandes, Andrea Baines, Rachel Ershler, Vishal Bhatnagar, Elizabeth Pulte, Thomas Gwise, Marc R. Theoret, Richard Pazdur, Lola Fashoyin-Aje, Nicole Gormley

Blood (2023) 142 (3): 235–243.

https://doi.org/10.1182/blood.2022018657

Published: 2023

Journal Articles

Patient- and Clinician-Reported Performance Status in Patients with Multiple Myeloma Treated in the United States Using Real World Data

Vishal Bhatnagar, Bindu Kanapuru, Laura Fernandes, Ting-Yu Chen, Mallorie H. Fiero, Erica Horodniceanu, Nicole Gormley, Catherine Lerro, Fatima Rizvi, Yuan-Li Shen, Felice Yang, Anna Barcellos, Andrew J. Belli, Eric Hansen, Ching-Kun Wang, Donna Rivera, Paul Kluetz

Blood (2022) 140 (Supplement 1): 7156–7157.

https://doi.org/10.1182/blood-2022-166842

Published: 2022

Journal Articles

FDA Analysis of Outcomes in Older Adults with Relapsed or Refractory Multiple Myeloma

Bindu Kanapuru, MD, Susan Jin, Kunthel By, Yuan Li Shen, PhD, Theresa Carioti, Nicole Gormley, MD, Ann T. Farrell, MD, Richard Pazdur, MD

Blood (2018) 132 (Supplement 1): 3287.

https://doi.org/10.1182/blood-2018-99-118597

Published: 2018

Journal Articles

FDA Analysis of Racial Demographics in Multiple Myeloma Trials

Vishal Bhatnagar, MD, Nicole Gormley, MD, Dickran Kazandjian, MD, Kirsten Goldberg, MA, Amy E. McKee, MD, Gideon Blumenthal, MD, Ann T. Farrell, MD, Richard Pazdur, MD

Blood (2017) 130 (Supplement 1): 4352.

https://doi.org/10.1182/blood.V130.Suppl_1.4352.4352

Published: 2017

Journal Articles

NK Cell KIR Ligand Mismatches Influence Engraftment Following Combined Haploidentical and Umbilical Cord Blood (UCB) Transplantation In Patients With Severe Aplastic Anemia (SAA)

Ritesh Kotecha, Xin Tian, PhD, Jennifer Wilder, RN, Nicole Gormley, MD, Hahn Khuu, MD, David Stroncek, MD, Susan F. Leitman, MD, Roger Kurlander, MD, Elena Cho, RN, MSN, Lisa Cook, RN, BSN, Catalina Ramos, RN, BSN, Ladan Foruraghi, CRNP, Charles D. Bolan, Jr., MD, Richard W. Childs, MD

Blood (2013) 122 (21): 2038.

https://doi.org/10.1182/blood.V122.21.2038.2038

Published: 2013

Journal Articles

Inhaled Cyclosporine For The Treatment Of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) Or Lung Transplantation

Nicole Gormley, MD, Catalina Ramos, RN, BSN, Robert Reger, Margaret Tropea, Xin Tian, PhD, Elena Cho, RN, MSN, Debra Reda, RN, Michael Terrin, MD, Leigh Samsel, MS, Millie Whatley, James Shelhamer, MD, Clara C. Chen, MD, Minoo Battiwalla, MD, MS, A. John Barrett, Tim Corcoran, PhD, Aldo Iacono, MD, J. Philip McCoy, PhD, Anthony Suffredini, MD, Richard W. Childs, MD

Blood (2013) 122 (21): 2057.

https://doi.org/10.1182/blood.V122.21.2057.2057

Published: 2013

Journal Articles

Adoptively-Infused NK Cells Maintain Their Antitumor Effects in Vivo in the Presence of CyclosporineA (CSA)

Hisayuki Yokoyama, Andreas Lundqvist, Maria Berg, Muthalagu Ramanathan, Rebecca Lopez, Aleah Smith, Nicole Gormley, Su Su, J. Phillip McCoy, Richard W. Childs, MD

Blood (2008) 112 (11): 2563.

https://doi.org/10.1182/blood.V112.11.2563.2563

Published: 2008

NARROW

Underrepresentation of Older Adults in Clinical Trials of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hematologic Malignancies: An FDA Analysis

Underrepresentation of Racial and Ethnic Minorities in Registrational Chimeric Antigen Receptor (CAR) T-Cell Therapy Trials in Hematologic Malignancies: An FDA Analysis

Eligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trials

Patient- and Clinician-Reported Performance Status in Patients with Multiple Myeloma Treated in the United States Using Real World Data

FDA Analysis of Outcomes in Older Adults with Relapsed or Refractory Multiple Myeloma

FDA Analysis of Racial Demographics in Multiple Myeloma Trials

NK Cell KIR Ligand Mismatches Influence Engraftment Following Combined Haploidentical and Umbilical Cord Blood (UCB) Transplantation In Patients With Severe Aplastic Anemia (SAA)

Inhaled Cyclosporine For The Treatment Of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) Or Lung Transplantation

Adoptively-Infused NK Cells Maintain Their Antitumor Effects in Vivo in the Presence of CyclosporineA (CSA)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only